ATE4956T1 - Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung. - Google Patents

Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.

Info

Publication number
ATE4956T1
ATE4956T1 AT80303912T AT80303912T ATE4956T1 AT E4956 T1 ATE4956 T1 AT E4956T1 AT 80303912 T AT80303912 T AT 80303912T AT 80303912 T AT80303912 T AT 80303912T AT E4956 T1 ATE4956 T1 AT E4956T1
Authority
AT
Austria
Prior art keywords
preparation
nitroglycerine
medications
possibly
manufacture
Prior art date
Application number
AT80303912T
Other languages
English (en)
Inventor
Stewart Thomas Leslie
Alan Rhodes
Original Assignee
Mundipharma A.G.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mundipharma A.G. filed Critical Mundipharma A.G.
Application granted granted Critical
Publication of ATE4956T1 publication Critical patent/ATE4956T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT80303912T 1979-11-06 1980-11-04 Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung. ATE4956T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7938380 1979-11-06
EP80303912A EP0028526B1 (de) 1979-11-06 1980-11-04 Nitroglycerin enthaltendes Präparat und möglicherweise andere Medikamente und deren Herstellung

Publications (1)

Publication Number Publication Date
ATE4956T1 true ATE4956T1 (de) 1983-10-15

Family

ID=10508999

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80303912T ATE4956T1 (de) 1979-11-06 1980-11-04 Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.

Country Status (6)

Country Link
US (2) US4322433A (de)
EP (1) EP0028526B1 (de)
AT (1) ATE4956T1 (de)
CA (1) CA1163561A (de)
DE (1) DE3065315D1 (de)
GB (1) GB2062465B (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
US4450175A (en) * 1982-09-23 1984-05-22 Warshaw Thelma G Method and compositions for treating acne
JPS59139315A (ja) * 1983-01-31 1984-08-10 Taisho Pharmaceut Co Ltd クリ−ム剤
DE3333639A1 (de) * 1983-09-17 1985-03-28 Dynamit Nobel Ag Zubereitung von nitroestern fuer die koronartherapie
US4764381A (en) * 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US5204339A (en) * 1986-01-31 1993-04-20 Whitby Research, Inc. Penetration enhancers for transdermal delivery of systemic agents
US5196410A (en) * 1986-10-31 1993-03-23 Pfizer Inc. Transdermal flux enhancing compositions
US4775529A (en) * 1987-05-21 1988-10-04 Schering Corporation Steroid lotion
US4879308A (en) * 1987-08-11 1989-11-07 Lyphomed, Inc. Aqueous nitroglycerin injection and manufacturing process
US5110809A (en) * 1988-03-21 1992-05-05 Bristol-Myers Squibb Company Antifungal gel formulations
US5002938A (en) * 1988-03-21 1991-03-26 Bristol-Myers Squibb Company Antifungal gel formulations
US5183665A (en) * 1989-01-23 1993-02-02 Nitto Denko Corporation Composition for percutaneous administration and method for enhancing percutaneous absorption of a physiologically active ingredient empolying the same
US5091186A (en) * 1989-08-15 1992-02-25 Cygnus Therapeutic Systems Biphasic transdermal drug delivery device
US5262165A (en) * 1992-02-04 1993-11-16 Schering Corporation Transdermal nitroglycerin patch with penetration enhancers
US5240917A (en) * 1991-04-03 1993-08-31 Keimowitz Rudolph M Suppression of thromboxane levels by percutaneous administration of aspirin
US5679337A (en) * 1991-06-14 1997-10-21 Professional Pharmaceutical, Inc. Method and composition for topical treatment of Aphthous stomatitis histamine using phosphate as active ingredient
US5234690A (en) * 1991-08-23 1993-08-10 Cygnus Therapeutic Systems Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
US5273756A (en) * 1991-08-23 1993-12-28 Cygnus Therapeutic Systems Transdermal drug delivery device using a membrane-protected microporous membrane to achieve delayed onset
US6071896A (en) * 1992-06-16 2000-06-06 Gundersen Clinic, Ltd. Suppression of thromboxane levels by percutaneous administration of aspirin
US5268046A (en) * 1992-08-14 1993-12-07 Hercules Incorporated Surfactant stabilized nitroglycerin emulsion
US5698589A (en) * 1993-06-01 1997-12-16 International Medical Innovations, Inc. Water-based topical cream containing nitroglycerin and method of preparation and use thereof
DE69432703T2 (de) * 1994-03-02 2004-03-25 Professional Pharmaceutical, Inc., Albuquerque Verwendung einer Zusammensetzung enthaltend Histaminphosphat zur Herstellung eines Medikaments zur topischen Behandlung von epithelialen Entzündungen oder Läsionen
EP0719145B1 (de) * 1994-05-27 2000-09-06 Cellegy Pharmaceuticals, Inc. Stickstoffoxyd abgebendes präparat zur behandlung von analen erkrankungen
US5703073A (en) * 1995-04-19 1997-12-30 Nitromed, Inc. Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
US6063405A (en) * 1995-09-29 2000-05-16 L.A.M. Pharmaceuticals, Llc Sustained release delivery system
US6036977A (en) * 1995-09-29 2000-03-14 L.A.M. Pharmaceutical Corp. Drug preparations for treating sexual dysfunction
US5952006A (en) * 1995-09-29 1999-09-14 L.A.M. Pharmaceuticals, Llc Drug preparations for treating impotency
SE520811C2 (sv) * 1997-01-17 2003-08-26 Ponsus Ab Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav
GB9711032D0 (en) * 1997-05-30 1997-07-23 Johnson Matthey Plc Compound as a stimulant for the central nervous system
AU756136B2 (en) * 1997-06-23 2003-01-02 Queen's University At Kingston Microdose therapy
DE19819012A1 (de) * 1998-04-29 1999-11-25 Dynamit Nobel Ag Feuersichere, nicht explosionsfähige, Nitroglycerin und wasserfreie Lactose enthaltende Feststoffmischungen
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
KR20100036390A (ko) 2001-03-06 2010-04-07 셀러지 파마세우티칼스, 인크 비뇨생식기 장애 치료용 화합물 및 그 방법
US20030035839A1 (en) * 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
CN100384422C (zh) * 2001-10-12 2008-04-30 爱克加股票上市公司 包含金属离子螯合剂的抗微生物组合物
US6863901B2 (en) * 2001-11-30 2005-03-08 Collegium Pharmaceutical, Inc. Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
US6827946B2 (en) * 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
PT1525200E (pt) * 2002-08-02 2008-01-10 Ab Science 2-(3-aminoaril)amino-4-aril-tiazóis para o tratamento de doenças
US8450302B2 (en) * 2002-08-02 2013-05-28 Ab Science 2-(3-aminoaryl) amino-4-aryl-thiazoles and their use as c-kit inhibitors
US7041286B2 (en) * 2003-07-23 2006-05-09 Nerenberg Arnold P Composition for mitigating a pernicious thrombotic event
EP1684750B1 (de) * 2003-10-23 2010-04-28 AB Science 2-aminoaryloxazol-verbindungen als tyrosinkinase-hemmer
CN101217954B (zh) 2005-04-04 2013-07-10 Ab科学公司 经取代的噁唑衍生物及其作为酪氨酸激酶抑制剂的用途
FR2892936A1 (fr) * 2005-11-10 2007-05-11 Galderma Res & Dev Composition pharmaceutique ou cosmetique, et procede de solubilisation mixte pour preparer la composition.
EP2120945A1 (de) * 2007-02-28 2009-11-25 Collegium Pharmaceutical, Inc. Antihistamin-kombination
EP2309993A1 (de) 2008-06-25 2011-04-20 US Worldmeds LLC Hautpflaster und lofexidin enthaltende formulierungen mit verzögerter freisetzung zur transdermalen und oralen verabreichung
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
AU2011206621B2 (en) 2010-01-12 2016-04-14 Ab Science Thiazole and oxazole kinase inhibitors
WO2011092273A1 (en) 2010-01-28 2011-08-04 Ab Science Treatment of gist with masitinib
AU2012288900B2 (en) 2011-07-27 2016-10-06 Ab Science Selective protein kinase inhibitors
CN106414433A (zh) 2014-03-24 2017-02-15 Ab科学有限公司 作为脾酪氨酸激酶抑制剂的二氮杂螺烷酮取代的噁唑衍生物
EP3053920B1 (de) 2015-02-05 2020-04-08 AB Science Verbindungen mit antitumoraktivität
EP3144307A1 (de) 2015-09-18 2017-03-22 AB Science Neue oxazol derivaten als syk kinasehemmer
JP2021506958A (ja) 2017-12-13 2021-02-22 オンクォリティ ファーマシューティカルズ チャイナ エルティーディーＯｎｑｕａｌｉｔｙ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｈｉｎａ Ｌｔｄ． Ｅｇｆｒ阻害に関連する疾患を予防又は治療する方法
AU2019254237B2 (en) 2018-04-16 2025-01-30 Onquality Pharmaceuticals China Ltd. Method for preventing or treating side effects of cancer therapy
US12070440B2 (en) 2022-06-27 2024-08-27 Permeatus, Inc. Topical formulations of nitroglycerin

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3395215A (en) * 1964-10-15 1968-07-30 Colgate Palmolive Co Pressurized lotion composition
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3609102A (en) * 1969-10-02 1971-09-28 Paris Cosmetics Inc Multicolored transparent polymer gel emollient bases, with oil-miscible dyes, for oil-soluble cosmetics, perfume and pharmaceuticals
US3789119A (en) * 1971-06-01 1974-01-29 Parke Davis & Co Stabilized molded sublingual nitroglycerin tablets
US4197318A (en) * 1974-07-08 1980-04-08 Johnson & Johnson Potentiated antimicrobial medicaments
US4112115A (en) * 1976-11-08 1978-09-05 Coghlan Charles C Therapy of leg muscle cramps
CA1163561A (en) * 1979-11-06 1984-03-13 Cyril Boroda Preparation containing nitroglycerine and optionally other medicaments and preparation thereof
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法

Also Published As

Publication number Publication date
US4322433A (en) 1982-03-30
EP0028526B1 (de) 1983-10-12
GB2062465A (en) 1981-05-28
EP0028526A3 (en) 1981-11-25
EP0028526A2 (de) 1981-05-13
GB2062465B (en) 1984-01-25
DE3065315D1 (en) 1983-11-17
CA1163561A (en) 1984-03-13
US4654209A (en) 1987-03-31

Similar Documents

Publication Publication Date Title
ATE4956T1 (de) Nitroglycerin enthaltendes praeparat und moeglicherweise andere medikamente und deren herstellung.
IT1230742B (it) Composizione per aerosol comprendente nitroglicerina come ingrediente attivo.
MX9202407A (es) Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion.
ES8800037A1 (es) Procedimiento para solubilizar drogas en propulsores de aerosol a base de clorofluorcarburos
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
ES488168A0 (es) Proceso para la preparacion de tabletas farmaceuticas o medicinales de administracion oral, con liberacion retardada delagente activo, en tabletas en las que la cantidad de libera-cion del agente activo es predeterminada.
KR900007837A (ko) 퀴누클리딘, 약제로서 이의 용도 및 이의 제조방법
ATE84032T1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
FI870457A0 (fi) Farmaceutiska preparatformer foer stabilisering av interferon- .
KR860000865A (ko) 약제 제형의 제조방법
JPS542316A (en) Solid pharmaceutical composition containing nifedipene
DE69119810D1 (de) Pyrogensorbentmittel
IE781032L (en) Pharmaceutical compositions
ES2027773T3 (es) Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea.
IL61207A0 (en) Cytostatically active pharmaceutical compositions comprising isocyanuric acid derivatives, certain such novel derivatives and their preparation
ATE1734T1 (de) Schmerzstillende tablette und verfahren zu deren herstellung.
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
AU566228B2 (en) Compressed hydroxybutryic acid polymer retarded release vehicle
GB2021409A (en) Pharmaceutical composition
JPS5350141A (en) Stabilization of prostaglandin and prostaglandin analogues
GB999739A (en) Analgesic compositions
ATE14437T1 (de) Aminoglycosid-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zusammensetzungen und solche derivate zur verwendung als arzneimittel.
GR1002731B (el) Φαρμακευτικα ενεσιμα διαλυματα περιεχοντα συνδυασμους παρακεταμολης με αλλες δραστικες ουσιες.
NL7511662A (nl) Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten.
KR890001556A (ko) 약제학적 조성물

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee